Projects per year
Personal profile
Academic Biography
Peixun Zhou is a Scientific Experimental Officer at the National Horizons Centre (NHC), and works on research, collaboration, teaching and training, as well as supporting facilities at NHC including flow cytometry and confocal microscopy.
Peixun has extensive experience in various molecular and cellular skills such as multi-colour flow cytometry, confocal fluorescence imaging, Raman confocal microscopy, gene editing with CRISPR/Cas9, mammalian cell culture, real-time quantitative PCR, gel electrophoresis and Sanger sequencing, Western blotting, cytogenetics, and next-generation sequencing, as well as experimental design, data analysis and troubleshooting.
Peixun has been working on various collaborative research projects with academic and industrial partners, and also providing trainings to academics and PhD students at NHC as well as to industrial collaborators through CPD training courses.
Peixun has a PhD from the University of Glasgow and over 6 years of post-doctoral research at Newcastle University, gaining extensive experience while working on various types of cancers.
My research interests are:
- Novel cancer treatment and therapeutics.
- Biomarker identification and risk stratification in cancer.
- Genomic abnormalities and their functional roles in cancer development and progression.
External Roles and Professional Activities
European Hematology Association (EHA)
British Society for Haematology (BSH)
Education/Academic qualification
Bachelor, BSc (Hons) in Cell Biology , Durham University
Master, MRes in Medical and Molecular Biosciences (Cancer Research) , Newcastle University
PhD, PhD in Haematology, University of Glasgow
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 2 Active
-
Determining the impact of microglial autophagy on neuroinflammatory responses
Zhou, P. (CoI)
17/04/24 → 31/03/25
Project: Research
-
Assessing homologous recombination repair function in response to RAD51 inhibitor
Sharma Saha, S. (PI), Zhou, P. (RA), Karunakaran, K. (CoI) & Jennings, C. (RA)
1/06/22 → 31/05/25
Project: Research
-
Confocal Laser Scanning Imaging of Cell Junctions in Human Colon Cancer Cells
Zhou, P. & Juanes, M. A., 14 Jun 2023, Intestinal Differentiated Cells. Methods in Molecular Biology. Ordóñez-Morán, P. (ed.). Humana Press, Vol. 2650. p. 245-259 15 p. Chapter 19. (Methods in Molecular Biology; vol. 2650).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia
Pal, D., Blair, H., Parker, J., Hockney, S., Beckett, M., Singh, M., Tirtakusuma, R., Nelson, R., McNeill, H., Angel, S. H., Wilson, A., Nizami, S., Nakjang, S., Zhou, P., Schwab, C., Sinclair, P., Russell, L. J., Coxhead, J., Halsey, C. & Allan, J. M. & 4 others, , 16 Aug 2022, In: Cell Reports Medicine. 3, 8, 100717.Research output: Contribution to journal › Article › peer-review
Open Access -
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development
Danilenko, M., Zaka, M., Keeling, C., Crosier, S., Lyman, S., Finetti, M., Williamson, D., Hussain, R., Coxhead, J., Zhou, P., Hill, R. M., Hicks, D., Rand, V., Joshi, A., Schwalbe, E. C., Bailey, S. & Clifford, S. C., 1 Sept 2022, In: Acta Neuropathologica. 144, 3, p. 565-578 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile68 Downloads (Pure) -
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Newman, A., Zaka, M., Zhou, P., Blain, A. E., Erhorn, A., Barnard, A., Crossland, R. E., Wilkinson, S., Enshaei, A., Zordi, J. D., Harding, F., Taj, M., Wood, K. M., Televantou6, D., Turner, S. D., Burke, G. A. A., Harrison, C. J., Bomken, S., Bacon, C. M. & Rand, V., 21 Oct 2021, In: Leukemia. e-pubResearch output: Contribution to journal › Article › peer-review
Open AccessFile211 Downloads (Pure) -
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia
Ciardullo, C., Szoltysek, K., Zhou, P., Pietrowska, M., Marczak, L., Willmore, E., Enshaei, A., Walaszczyk, A., Ho, J. Y., Rand, V., Marshall, S., Hall, A., Harrison, C. J., Soundararajan, M. & Eswaran, J., 21 Dec 2021, In: Cancers. 14, 1, 23.Research output: Contribution to journal › Article › peer-review
Open AccessFile109 Downloads (Pure)
Press/Media
-
Teesside University researchers in cancer treatment breakthrough
11/09/21
1 item of Media coverage
Press/Media: Press / Media
-
-
-
Pharmacists to oversee nutritional cure of diabetes?
1/10/21
1 item of Media coverage
Press/Media: Press / Media